The Government assigns the Swedish Agency for innovation system (Vinnova) to establish a programme for advanced life science. Furthermore, the authority will continue support the establishment of the Centre for Commercialization of Regenerative Medicine Nordic (CCRM Nordic).
The assignment must be reported no later than March 17, 2028.